cbdMD (YCBD) Non-Current Deferred Tax Liability (2016 - 2021)

cbdMD (YCBD) reported Non-Current Deferred Tax Liability of $6.1 million for Q3 2021, up 583.35% on a YoY basis from $895000.0 in Q3 2020, and up 4604.62% sequentially from $130000.0 in Q2 2021.

cbdMD (YCBD) Non-Current Deferred Tax Liability (2016 - 2021) Analysis & Trends

cbdMD (YCBD) has 6 years of Non-Current Deferred Tax Liability data on file, last reported at $6.1 million in Q3 2021.

  • For the quarter ending Q3 2021, Non-Current Deferred Tax Liability rose 583.35% year-over-year to $6.1 million; the trailing twelve-month figure through Sep 2021 stood at $6.1 million (up 583.35% YoY), and the FY2021 full-year result was $6.1 million, up 583.35% from the prior year.
  • Non-Current Deferred Tax Liability rose to $6.1 million in Q3 2021, from $130000.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $6.1 million in Q3 2021 to a low of $15000.0 in Q4 2017.
  • A 5-year average of $1.7 million and a median of $563000.0 in 2020 frame the typical range for Non-Current Deferred Tax Liability.
  • Across the five-year window, Non-Current Deferred Tax Liability surged 33206.67% in 2018 and sank 60.05% in 2020, its largest moves.
  • Tracing YCBD's Non-Current Deferred Tax Liability over 5 years: stood at $15000.0 in 2017, then surged by 33206.67% to $5.0 million in 2018, then plunged by 55.16% to $2.2 million in 2019, then sank by 74.87% to $563000.0 in 2020, then soared by 986.32% to $6.1 million in 2021.
  • Business Quant data shows YCBD's Non-Current Deferred Tax Liability at $6.1 million in Q3 2021, $130000.0 in Q2 2021, and $27000.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 cbdMD 438,678.80 -2.95 Mn 3.00 Mn

Historic Data

Download Data
DateValue
Sep 30, 2021 6.12 Mn
Sep 30, 2021 6.12 Mn
Jun 30, 2021 130,000.00
Jun 30, 2021 130,000.00
Mar 31, 2021 27,000.00
Mar 31, 2021 27,000.00
Dec 31, 2020 563,000.00
Dec 31, 2020 563,000.00
Sep 30, 2020 895,000.00
Sep 30, 2020 895,000.00
Sep 30, 2019 2.24 Mn
Sep 30, 2019 2.24 Mn
Jun 30, 2019 2.83 Mn
Jun 30, 2019 2.83 Mn
Mar 31, 2019 3.92 Mn
Mar 31, 2019 3.92 Mn
Dec 31, 2018 5.00 Mn
Dec 31, 2018 5.00 Mn
Sep 30, 2018 21,000.00
Sep 30, 2018 21,000.00